Bill proposes to freeze FDA funds:
This article was originally published in Clinica
A House of Representatives subcommittee last Wednesday voted to freeze FDA funds at the current level: $917.7 million in salaries and expenses. The panel made no recommendations for medical device user fees. It did, however, recommend that some current enforcement and administrative funds be transferred to medical device functions. The subcommittee also discussed reducing the size of the FDA Commissioner's office - but gave no definite directions. The measure is due to go before the full Appropriations Committee this week.
You may also be interested in...
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.
The FDA has almost 30 decision dates coming up before New Year’s Eve, including nearly a dozen novel agents.